Mason Street Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,640	Closed	-$274K	–	78
2020 Q4	$274K	Sell	13,640 -78	-0.6%	-$1.52K	﹤0.01%	1343
2020 Q3	$257K	Buy	13,718 +1,057	+8%	+$21.3K	0.01%	1278
2020 Q2	$284K	Buy	12,661 +726	+6%	+$13.3K	0.01%	1254
2020 Q1	$177K	Hold	11,935	–	–	﹤0.01%	1305
2019 Q4	$230K	Buy	11,935 +229	+2%	+$4.39K	﹤0.01%	1356
2019 Q3	$232K	Sell	11,706 -77	-0.7%	-$1.6K	﹤0.01%	1336
2019 Q2	$249K	Buy	11,783 +680	+6%	+$14.2K	0.01%	1301
2019 Q1	$227K	Buy	11,103 +366	+3%	+$8.2K	﹤0.01%	1368
2018 Q4	$214K	Buy	10,737 +458	+4%	+$9.03K	0.01%	1300
2018 Q3	$198K	Sell	10,279 -86	-0.8%	-$1.53K	﹤0.01%	1376
2018 Q2	$158K	Buy	10,365 +544	+6%	+$9.51K	﹤0.01%	1428
2018 Q1	$184K	Buy	9,821 +613	+7%	+$11.5K	﹤0.01%	1358
2017 Q4	$177K	Buy	9,208 +199	+2%	+$3.72K	﹤0.01%	1359
2017 Q3	$161K	Buy	9,009 +211	+2%	+$3.47K	﹤0.01%	1367
2017 Q2	$157K	Buy	8,798 +404	+5%	+$6.41K	﹤0.01%	1356
2017 Q1	$122K	Buy	8,394 +549	+7%	+$8.63K	﹤0.01%	1398
2016 Q4	$145K	Buy	7,845 +1,389	+22%	+$27K	﹤0.01%	1342
2016 Q3	$122K	Buy	+6,456	New	+$117K	﹤0.01%	1343